![]() |
市場調査レポート
商品コード
1504234
眼内レンズの市場規模、シェア、予測、動向分析、タイプ別、材料別、用途別、エンドユーザー別-2031年までの世界の予測Intraocular Lens Market Size, Share, Forecast, & Trends Analysis by Type (Monofocal, Multifocal, Toric, Phakic) Material (Hydrophobic Acrylic, PMMA, Silicone) Application (Cataract, Astigmatism, Corneal Disorders) End User - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
眼内レンズの市場規模、シェア、予測、動向分析、タイプ別、材料別、用途別、エンドユーザー別-2031年までの世界の予測 |
出版日: 2024年06月01日
発行: Meticulous Research
ページ情報: 英文 250 Pages
納期: 5~7営業日
|
眼内レンズ市場は、2024年から2031年までのCAGR6.5%で、2031年には71億7,000万米ドルに達すると予測されます。
本レポートは、包括的な一次および二次調査、市場シナリオの詳細な分析に基づき、業界の主要促進要因、制約、課題、機会を提供します。この市場を牽引しているのは、高齢者人口の増加、白内障手術件数の増加、デジタル機器の使い過ぎによる視覚障害、眼科医療サービスへのアクセシビリティを向上させるための政府の取り組みや資金援助などです。
さらに、低侵襲の眼科手術に対する嗜好の高まりは、この市場に大きな成長機会をもたらしています。しかし、眼内レンズのコストが高く、償還政策が利用できないことが成長を抑制する可能性があります。さらに、眼内レンズのまれな合併症は、この市場で活動するプレーヤーに課題を突きつけています。
(注:上位5社のSWOT分析を掲載)
Intraocular Lens Market Size, Share, Forecast, & Trends Analysis by Type (Monofocal, Multifocal, Toric, Phakic) Material (Hydrophobic Acrylic, PMMA, Silicone) Application (Cataract, Astigmatism, Corneal Disorders) End User-Global Forecast to 2031
The intraocular lens market is projected to reach $7.17 billion by 2031, at a CAGR of 6.5% from 2024 to 2031.
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising geriatric population, increasing number of cataract surgeries, visual impairment due to excessive use of digital devices, and government initiatives and funding to improve accessibility to eye care services.
Furthermore, the rising preference for minimally invasive ophthalmic surgeries provides a significant growth opportunity for this market. However, the high costs of intraocular lenses and the unavailability of reimbursement policies may restrain its growth. Additionally, rare complications of IOL pose a challenge for the players operating in this market.
Among types, in 2024, the multifocal intraocular lenses segment is expected to account for the largest share of 28.9% of the intraocular lens market. The large share of the segment is attributed to factors such as proven/predictable results, cost-effectiveness, minimum maintenance, and the high prevalence of cataracts in older people. The key market players are undertaking various strategic initiatives to innovate multifocal intraocular lenses. For instance, in July 2022, Lenstec, Inc. (U.S.) received U.S. Food and Drug Administration (FDA) approval for the SBL-3 Multifocal Intraocular Lens (IOL), which is permanently implanted inside the eye. The SBL-3 is a multifocal intraocular lens with two zones that focus light-one from objects far away (distance vision) and the other from objects close up (near vision).
Among materials, in 2024, the hydrophobic acrylic segment is expected to account for the largest share of the intraocular lens market. Hydrophobic acrylic is the most commonly used type of material in IOLs. This material is composed of crosslinked copolymers of acrylic esters and other acrylic ester co-monomers, with a carbon backbone and ester side groups. The large share of the segment is attributed to factors such as the increasing popularity of ophthalmologists, good mechanical stability, good uveal biocompatibility, ease of manufacturing, and lower rates of complications in IOL.
Among applications, in 2024, the cataract surgery segment is expected to account for the largest share of the intraocular lens market. The large share of the segment is attributed to factors such as the increasing number of cataract surgeries, growing demand for intraocular lenses, and increasing technological advancements in intraocular lenses.
Among end users, in 2024, the hospitals products segment is expected to account for the largest share of the intraocular lens market. The large share of the market is attributed to factors such as the increasing prevalence of eye diseases and disorders and increasing awareness of ocular diseases leading to rising visits to hospitals.
An in-depth analysis of the geographical scenario of the intraocular lens market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2024, Asia-Pacific is slated to register the highest CAGR of 8.5% of the intraocular lens market. The high growth of the segment is primarily attributed to the rising geriatric population in countries such as China and India, the adoption of advanced healthcare resources, and rising awareness regarding the benefits of vision care products. Furthermore, the increasing affordability and availability of vision treatment providers also contribute to the growth of this market.
The key players operating in the intraocular lens market are Alcon, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), Beaver-Visitec International (U.S.), Ophtec B.V. (Netherlands), Appasamy Associates Private Limited (India), Atia Vision, Inc. (U.S.), LENSTEC, Inc. (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Rayner Group (U.K.), EyeKon Medical, Inc. (U.S.), and Humanoptics Holding AG (Germany).
Intraocular Lens Market-by Type
(Other lenses include extended depth-of-focus (EDOF) lenses and light adjustable lenses, among others)
Intraocular Lens Market-by Material
(Other materials include Collamer (Collagen+Polymer) and PEG-PHS/HEMA/Styrene (PHS) Copolymer, among others)
Intraocular Lens Market-by Application
(Other applications include presbyopia, nearsightedness, and farsightedness)
Intraocular Lens Market-by End User
Intraocular Lens Market-by Geography
(Note: SWOT analysis of the top 5 companies is provided.)